Literature DB >> 24744196

Underestimation rate of lobular intraepithelial neoplasia in vacuum-assisted breast biopsy.

Stefano Meroni, Meroni Stefano1, Anna Carla Bozzini, Bozzini Anna Carla, Giancarlo Pruneri, Pruneri Giancarlo, Oana Codrina Moscovici, Moscovici Oana Codrina, Patrick Maisonneuve, Maisonneuve Patrick, Simona Menna, Menna Simona, Silvia Penco, Penco Silvia, Lorenza Meneghetti, Meneghetti Lorenza, Giuseppe Renne, Renne Giuseppe, Enrico Cassano, Cassano Enrico.   

Abstract

OBJECTIVES: To evaluate the underestimation rate and clinical relevance of lobular neoplasia in vacuum-assisted breast biopsy (VABB).
METHODS: A total of 161 cases of LN were retrieved from 6,435 VABB. The histological diagnosis was ALH (atypical lobular hyperplasia) in 80 patients, LCIS (lobular carcinoma in situ) in 69 patients and PLCIS (pleomorphic lobular carcinoma in situ) in 12 patients. Seventy-six patients were operated on within 2 years after VABB and 85 were clinically and radiologically monitored. The mean follow-up was 5.2 years, and the prevalence of malignancy was evaluated in the group of 85 patients.
RESULTS: The clinico-pathological characteristics significantly favouring surgery were larger lesions, occurrence of a residual lesion following VABB and histological LCIS and PLCIS subtypes. The VABB underestimation rate as compared to surgery was 7.1% for ALH, 12% for LCIS and 50% for PLCIS. Overall, 11 of the 148 patients included in this survival analysis developed an ipsilateral tumour.
CONCLUSION: Although obtained retrospectively in a relatively small series of patients, our data suggest that only patients with a diagnosis of PLCIS in VABB should be treated with surgery, whereas patients with ALH and LCIS could be monitored by clinical and radiological examinations. KEY POINTS: • The treatment of ALH and LCIS in VABB is still debated • Some authors favour radical treatment and others a more conservative approach • Only patients with PLCIS in VABB should be treated by surgery.

Entities:  

Mesh:

Year:  2014        PMID: 24744196     DOI: 10.1007/s00330-014-3132-y

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  35 in total

1.  Lobular carcinoma in situ of the breast. Detailed analysis of 99 patients with average follow-up of 24 years.

Authors:  P P Rosen; C Kosloff; P H Lieberman; F Adair; D W Braun
Journal:  Am J Surg Pathol       Date:  1978-09       Impact factor: 6.394

2.  Low frequency of cancer occurrence in same breast quadrant diagnosed with lobular neoplasia at percutaneous needle biopsy.

Authors:  Louise Provencher; Simon Jacob; Gary Côté; Jean-Charles Hogue; Christine Desbiens; Brigitte Poirier; Isabelle Raîche; Linda Le Régent; Caroline Diorio
Journal:  Radiology       Date:  2012-02-17       Impact factor: 11.105

3.  Follow-up surgical excision is indicated when breast core needle biopsies show atypical lobular hyperplasia or lobular carcinoma in situ: a correlative study of 33 patients with review of the literature.

Authors:  Tarik M Elsheikh; Jan F Silverman
Journal:  Am J Surg Pathol       Date:  2005-04       Impact factor: 6.394

4.  Lobular neoplasia at 11-gauge vacuum-assisted stereotactic biopsy: correlation with surgical excisional biopsy and mammographic follow-up.

Authors:  Mary C Mahoney; Toni M Robinson-Smith; Elizabeth A Shaughnessy
Journal:  AJR Am J Roentgenol       Date:  2006-10       Impact factor: 3.959

5.  Results of MR imaging screening for breast cancer in high-risk patients with lobular carcinoma in situ.

Authors:  Lauren C Friedlander; Susan Orel Roth; Sara C Gavenonis
Journal:  Radiology       Date:  2011-09-07       Impact factor: 11.105

Review 6.  Management of lobular carcinoma in-situ and atypical lobular hyperplasia of the breast--a review.

Authors:  M Hussain; G H Cunnick
Journal:  Eur J Surg Oncol       Date:  2011-04       Impact factor: 4.424

7.  Breast-conserving surgery and radiotherapy: a possible treatment for lobular carcinoma in situ?

Authors:  Bruno Cutuli; Brigitte de Lafontan; Philippe Quetin; Eliane Mery
Journal:  Eur J Cancer       Date:  2005-02       Impact factor: 9.162

8.  Long-term follow-up of lobular neoplasia (atypical lobular hyperplasia/lobular carcinoma in situ) diagnosed on core needle biopsy.

Authors:  Miraj G Shah-Khan; Xochiquetzal J Geiger; Carol Reynolds; James W Jakub; Elizabeth R Deperi; Katrina N Glazebrook
Journal:  Ann Surg Oncol       Date:  2012-07-31       Impact factor: 5.344

9.  Lobular neoplasia on core needle biopsy does not require excision.

Authors:  Chandandeep S Nagi; James E O'Donnell; Mikhail Tismenetsky; Ira J Bleiweiss; Shabnam M Jaffer
Journal:  Cancer       Date:  2008-05-15       Impact factor: 6.860

10.  The significance of atypical lobular hyperplasia at percutaneous breast biopsy.

Authors:  Karen Dmytrasz; Paul Ian Tartter; Howard Mizrachy; Lynn Chinitz; Sharon Rosenbaum Smith; Alison Estabrook
Journal:  Breast J       Date:  2003 Jan-Feb       Impact factor: 2.431

View more
  6 in total

Review 1.  How Do We Approach Benign Proliferative Lesions?

Authors:  Faina Nakhlis
Journal:  Curr Oncol Rep       Date:  2018-03-23       Impact factor: 5.075

Review 2.  American Registry of Pathology Expert Opinions: The Spectrum of Lobular Carcinoma in Situ: Diagnostic Features and Clinical Implications.

Authors:  Stuart J Schnitt; Edi Brogi; Yunn-Yi Chen; Tari A King; Sunil R Lakhani
Journal:  Ann Diagn Pathol       Date:  2020-02-15       Impact factor: 2.090

Review 3.  Positive predictive value for malignancy of uncertain malignant potential (B3) breast lesions diagnosed on vacuum-assisted biopsy (VAB): is surgical excision still recommended?

Authors:  Marco Lucioni; Chiara Rossi; Pascal Lomoro; Francesco Ballati; Marianna Fanizza; Alberta Ferrari; Carlos A Garcia-Etienne; Emanuela Boveri; Giulia Meloni; Maria Grazia Sommaruga; Elisa Ferraris; Angioletta Lasagna; Elisabetta Bonzano; Marco Paulli; Adele Sgarella; Giuseppe Di Giulio
Journal:  Eur Radiol       Date:  2020-08-20       Impact factor: 5.315

4.  Lobular carcinoma in situ of the breast - correlation between minimally invasive biopsy and final pathology.

Authors:  Bartłomiej Szynglarewicz; Piotr Kasprzak; Agnieszka Hałoń; Rafał Matkowski
Journal:  Arch Med Sci       Date:  2016-10-26       Impact factor: 3.318

5.  Suspicious amorphous microcalcifications detected on full-field digital mammography: correlation with histopathology.

Authors:  Vera Christina Camargo de Siqueira Ferreira; Elba Cristina Sá de Camargo Etchebehere; José Luiz Barbosa Bevilacqua; Nestor de Barros
Journal:  Radiol Bras       Date:  2018 Mar-Apr

6.  Reconsidering the therapeutic use for vacuum-assisted breast biopsy in breast cancer patients: a retrospective single-center study.

Authors:  Jialin Zhao; Xuejing Wang; Ying Xu; Li Peng; Qiang Sun
Journal:  Transl Cancer Res       Date:  2020-06       Impact factor: 1.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.